In the animal model, BA decreases serum prostate-specific antigen (PSA) levels by 88%, inhibits the LNCap tumour growth by 38% and reduces insulin-like growth factor-1 in nude mice injected with human LNCap prostate cancer cells15. The gene discussed is IGF1; the disease is prostate carcinoma.